| Literature DB >> 10231022 |
B H Shah1, A Siddiqui, K A Qureshi, M Khan, S Rafi, V A Ujan, M Y Yakoob, Y Yaqub, H Rasheed, S A Saeed.
Abstract
Our previous studies have shown that subthreshold concentrations of two platelet agonists exert synergistic effects on platelet aggregation. Here we studied the mechanism of synergistic interaction of 5-hydroxytryptamine (5-HT) and epinephrine mediated platelet aggregation. We show that 5-HT had no or little effect on aggregation but it did potentiate the aggregation response of epinephrine. The synergistic interaction of 5-HT (1-5 microM) and epinephrine (0.5-2 microM) was inhibited by alpha2-adrenoceptor blocker (yohimbine; IC50= 0.4 microM), calcium channel blockers (verapamil and diltiazem with IC50 of 10 and 48 mM, respectively), PLC inhibitor (U73122; IC50=6 microM) and nitric oxide (NO) donor, SNAP (IC50=1.6 microM)). The data suggest that synergistic effects of platelet agonists are receptor-mediated and occur through multiple signalling pathways including the activation PLC/Ca2+ signalling cascades.Entities:
Mesh:
Substances:
Year: 1999 PMID: 10231022 DOI: 10.1038/emm.1999.7
Source DB: PubMed Journal: Exp Mol Med ISSN: 1226-3613 Impact factor: 8.718